A 48-year-old woman presented to our hospital with dry cough and dyspnea for two weeks. She had no remarkable past medical history. She didn't complain of obvious chest pain.
INTRODUCTION
Pulmonary artery dissection is a disease causing high mortality. Over the past two centuries, approximately 50 cases with pulmonary artery dissection have been reported in the literature, including eight diagnosed while patients were alive (1) . Symptoms of pulmonary artery dissection are variable. It may start with acute onset of chest pain, dyspnea, and hemoptysis (2) (3) (4) . It may initially present with only ambiguous symptoms, such as respiration-associated pain or distress (5) .
These nonspecific symptoms can be caused by pulmonary artery sarcoma or pulmonary embolism shown as intraluminal pulmonary artery lesion on imaging studies. Several radiologic findings that we present in this case report can help the differentiation of pulmonary artery dissection from other mim-
ickers.
Pulmonary artery dissection is rarer than other intraluminal diseases of pulmonary artery such as pulmonary thromboembolism or pulmonary artery sarcoma. We report two cases of pulmonary artery dissection mimicking pulmonary artery sarcoma. Computed tomography (CT) showed no enhancement of intrapulmonary arterial lesion or expansion of involved pulmonary artery. Magnetic resonance imaging (MRI) showed low-signal intensity intimal flap on T1-and T2-weighted images. There was no fluorodeoxyglucose (FDG) uptake on positron emission tomography (PET)-CT. In this case report, we describe the imaging features of pulmonary artery dissection on CT, MRI, and PET-CT. 
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Case 2
A 68-year-old woman with a 7-day history of medical treatment for dry cough, general ache, and dyspnea in a local hospi- Pulmonary thromboembolism, pulmonary artery sarcoma, and pulmonary artery invasion by lung cancer may be observed to the left lower lobar artery. The lesion occupied the entire lumen of the pulmonary artery without luminal dilatation. Compared to contralateral pulmonary artery, the lesion was not enhanced ( Fig. 2A-C) . Positron emission tomography (PET)-CT showed no demonstrable increased fluorodeoxyglucose (FDG) uptake (Fig. 2D ).
For the treatment and confirmation of the diagnosis, pneumonectomy was done for these patients. Gross cross section of pulmonary artery showed hematoma in the lumen (Fig. 3A) .
Microscopic examination revealed that the smooth muscle layer was dissected ( Fig. 3B-D) . These patients were confirmed as pulmonary artery dissection.
DISCUSSION
Pulmonary artery dissection is a highly life-threatening disease.
Unlike aortic dissection, the false lumen in pulmonary artery dissection tends to rupture rather than to develop a re-entry site. It is Hematoma in late subacute stage (7 days to 30 days) is usually shown as high signal intensity on T1-and T2-weighted images (6) , corresponding to the two weeks history in our first case.
Pulmonary artery sarcoma is described as minimally higher signal intensity compared to that of chest wall muscle on T1-and T2-weighted images (7). According to the duration, hematoma can be represented with variable signal intensities on MRI.
Therefore, correlation with clinical history is required for differentiating hematoma from pulmonary artery sarcoma.
CT findings of pulmonary artery sarcoma are filling defect occupying the entire lumen of the main or proximal pulmonary arteries, expansion of any portion of the involved pulmonary artery, extraluminal extension, and heterogeneous enhancement (8). In the two cases that we presented, no enhancement or expansion of involved pulmonary artery was the important point in differentiating pulmonary artery dissection from pulmonary artery sarcoma. The standardized uptake values on FDG PET is useful to distinguish a benign tumor from a malignant tumor (9). Several case reports have revealed pulmonary artery sarcoma showed FDG uptake within the pulmonary artery on integrated PET-CT, whereas blood thrombi showed no FDG uptake (9, 10).
In our second case, there was no FDG uptake on PET-CT. 
